Category Archives: Health: Addiction

Addiction one of the Largest growing Problem’s in the world today. This Press Release Service will bring you the newest services and research available.

Health: Addiction

U.S. Career Institute and Premier Health Partner to Support Employee Growth and Solve Staffing Challenges through Education.

Leave a comment


This partnership will enable Premier Health to meet its staffing needs by attracting, developing, and retaining high-quality, Medical Assistants at its affiliated urgent care clinics. Medical Assistants that receive training through U.S. Career Institute will also be positioned to earn industry credentials, ensuring a well-trained, tenured, and patient-focused staff.

“I am excited about this partnership with U.S. Career Institute “stated Jared LeDoux, VP of Human Resources at Premier Health. “In addition to helping build clinical capabilities of our workforce, we are also engaging our front-line team members with opportunities to further their careers. We truly believe, here at Premier Health, that our team members can grow with us – no matter what healthcare path they wish to take. The Medical Assistant program through U.S. Career Institute allows team members the opportunity to learn at their own pace, providing them with instructional support and structured opportunities to practice their skills at the clinic-level.”

Janet Perry, VP of Academics and Compliance at U.S. Career Institute stated, “The rising concerns of labor shortages in the healthcare industry are here to stay, the healthcare industry is facing significant employee shortages from the top down, the U.S. faces a projected shortage of more than 3.2 million skilled healthcare workers such as medical assistants, home health aides and nursing assistants. This partnership contains proven strategies that can help fill critical entry level healthcare positions, while creating career ladders and investment back into the healthcare workforce that will result in developing expertise and retention. U.S. Career Institute is delighted to play a role in solving these challenges.”

About U.S. Career Institute

Weston Distance Learning, the parent company of U.S. Career Institute, has been providing distance education since 1981. By offering high-quality, career-focused online education at affordable prices, U.S. Career Institute has helped thousands of students reach their educational and career goals. U.S. Career Institute is accredited by the Distance Education Accrediting Commission (DEAC), which is listed by the U.S. Department of Education as a recognized accrediting agency. USCI’s curricula, administrative procedures, faculty, and policies are frequently reviewed to make sure that USCI continues to meet high standards of quality and service. To learn more about U.S. Career Institute, visit https://www.partners.uscareerinstitute.edu

About Premier Health

Founded in 1999, Premier Health is among the first urgent care operators in the nation to specialize in a health system branded, joint venture model. A recognized leader in the urgent care industry, Premier Health partners with some of the top health systems across the country including Trinity Health’s and its network of hospitals, HCA, Ardent, LCMC Health, UT Health East Texas and the University of Kansas Health System. Premier Health is committed to the delivery of excellent clinical care in a setting that offers each patient a next-level consumer experience. All of Premier’s clinics are nationally accredited by the Urgent Care Association. You can follow Premier Health on LinkedIn or Twitter. To learn more, go to https://premierhealthurgentcare.com

Media Contact

Holly Cook, U.S. Career Institute, 1 9702826357, [email protected], https://www.partners.uscareerinstitute.edu

SOURCE U.S. Career Institute

Health: Addiction

Improved Pharma expands laboratory space by 50% to accommodate recent growth in our research and development programs

Leave a comment


“We are very excited about our new lab space,” exclaims Dr. Byrn, CSO of Improved Pharma. “We will be able to house additional instrumentation and perform required experiments that are critical for development of compounds into life-saving drugs.”

About Improved Pharma
Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Services include solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting for the development and defense of intellectual property matters. The company was founded in 2006 by Stephen and Sarah Byrn, who also founded SSCI.

Media Contact

Pam Smith, Improved Pharma, (765) 463-9951, [email protected], https://improvedpharma.com/

SOURCE Improved Pharma

Health: Addiction

E Tech Group to Attend 2023 Annual ISPE Boston Area Chapter Product Show

Leave a comment


The E Tech Group team will be providing information around our IT/OT risk assessments, a helpful tool in addressing and mitigating issues at facilities. On the other end of the hall, still bearing E-Volve Systems logos and banners, E-Volve Systems will showcase their capabilities for oligonucleotide automation, an industry facing many opportunities for automation, in a featured demo. Attendees can learn how E Tech Group can help a batch process that is currently manual and facing inconsistency issues become a more efficient and safer process.

“E-Volve Systems, an E Tech Group company, is excited to once again be showcasing our expertise at the ISPE Product Show. We look forward to highlighting our experience with automating what was once a manual process in oligonucleotide manufacturing, connecting with our peers, clients, and new faces. Joining E Tech Group earlier this year we have expanded our capabilities and reach becoming a major player in the industry across North America. This is an exciting time in our company and in the industry; we are eager to go share all that is happening with the ISPE attendees,” said Vice President of Life Sciences Central Kevin Stout.

Among the booth attendees you’ll be able to find long-time show veteran and Hank Moes Award Recipient, Rick Pierro, E Tech Group’s Chief Strategy Officer for Life Sciences.

“We are excited to participate in the ISPE Product Show for our 24th consecutive year; we always look forward to the show,” said Pierro. “After being in business for 30 years, now that we’ve transitioned from Superior Controls into E Tech Group, I’m excited to come to the show as E Tech Group to see old and new faces at our booth as we showcase a nationwide team with over 400 engineers behind us. My team and I proudly support ISPE and their mission to connect pharmaceutical knowledge.”

To register to attend the ISPE Boston Area Chapter Product Show, look here. If you want to learn about career opportunities at E Tech Group, be sure to visit booth C12.

About E Tech Group

E Tech Group is one of the largest engineering and system integration firms in the United States. With offices throughout North America and more than 400 engineers, the company provides automation, control and information solutions to the Life Sciences, Mission Critical, Metals, Parcel, Consumer Products and Food & Beverage industries. In addition to its organic growth, E Tech Group has recently grown through the successful acquisition and integration of Glenmount Global Solutions, Superior Controls (and its subsidiary, Banks Integration) and now, E-Volve Systems. For more information, visit etechgroup.com. 

Media Contact

Georgia Whalen, Rivergate Marketing, 978-697-2664, [email protected], https://www.rivergatemarketing.com/

SOURCE E Tech Group

Health: Addiction

ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI

Leave a comment


Through AI, ClinCHAT utilizes the latest natural language processing (NLP) and machine learning algorithms to provide a frictionless experience for users navigating complex data queries, regardless of size or development stage. The new tool gives ProPharma seamless access to H1’s real world and clinical trial performance data – which includes a database of some 340 million patients, 10 million physicians and over 420,000 clinical trials – to increase confidence and overall success in clinical research.

“ClinCHAT and our continued partnership with H1 reflects ProPharma’s AI-first strategy and showcases our technology-enabled Research Consulting Organization business model,” said ProPharma’s Chief Strategy Officer and Head of Corporate Development, Bryan Katz. “ClinCHAT is an important tool for those innovators looking to de-risk decision making and accelerate the delivery of their programs with a higher probability of success.”

ProPharma is committed to improving clinical trial access through innovation. The introduction of ClinCHAT follows the launch of ProPharma’s Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.

About ProPharma
For over 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs .For more information about ProPharma, please visit: https://www.propharmagroup.com.

About H1
H1 connects the world to the right doctors. As the leading source of truth for global clinical and scientific information, H1 leverages next-gen analytics and AI to democratize access to HCP data, diversity insights, and groundbreaking research for life sciences, academic medical institutions, health systems, and payors.
The H1 data platform fuels a robust enterprise product suite that supports the advancement of healthcare innovation and equity. Today, more than 250 customers trust H1 to stay current with the latest information on HCPs everywhere, from clinical work and scholarly research to digital spheres of influence. H1 enables the meaningful connection with thought and treatment leaders to improve adherence to evidence-based medicine, inform inclusive clinical trial design, provide access to groundbreaking science, accelerate time to market, and ultimately, advance health equity. Learn more at https://www.h1.co.

ProPharma Media Inquiries and Contacts:

Zosya Popik
Vice President, Global Marketing
ProPharma
[email protected]

Steve Rensi
Senior Director, Global Brand Strategy & Communications
ProPharma
[email protected]

Jason Wakeford
Associate Partner
Clarity for ProPharma
[email protected]

H1 Media Inquiries and Contacts:

Lizzy Feliciano
Chief Marketing Officer
H1
[email protected]

Anya Nelson
Scratch Marketing + Media for H1
[email protected]

Media Contact

Jason Wakeford, Clarity for ProPharma, 424-385-4062, [email protected], https://www.propharmagroup.com/

SOURCE ProPharma

Health: Addiction

Convergent Dental Announces New Clinical Advisory Board to Help Shape the Future of Laser Dentistry and Patient Care

Leave a comment


“Solea is a multiplier at the center of the practice. It enables dentists to streamline current procedures and expand to new procedures while complementing adjacent technologies,” said Robert L. Gershon, CEO of Convergent Dental. “Our new clinical advisors have years of experience with Solea and understand firsthand the multitude of ways this laser can benefit patients and practices. We look forward to the insights they will bring to our growth strategy as we continue to drive the broad-based adoption of Solea.”

The new Convergent Clinical Advisory Board features the following Solea dentists. Dr. Tim Anderson founded Missouri River Dental as a startup private practice in Bismarck, ND. After receiving his Doctor of Dental Surgery from the University of Minnesota School of Dentistry, he completed his general practice residency at Hennepin County Medical Center (Level 1 Trauma Center).

His practice and philosophy are grounded in the belief that technology helps dentists to work smarter, have more fun, and ignite their passion for their business, all while improving the patient experience and achieving better clinical outcomes. He leverages CAD/CAM, CBCT, 3D printing, and CO2 laser technology to deliver comprehensive, quality oral health care that is patient-centered.

In addition to clinical dentistry, Dr. Anderson maintains a leadership role within the dental profession and lectures on various dental technology topics around the country. He is a Key Opinion Leader (KOL) in the areas of dental lasers and 3D Printing. He invests his time and knowledge as a faculty member at 3D Dentists to help other dental professionals nationally discover what digital technology can do for their practices.

Dr. Jeff Rohde currently maintains an innovative restorative and surgical practice in Santa Barbara, CA. He graduated from UCLA with a bachelor’s degree in microbiology and molecular genetics and a master’s degree in biochemistry. He continued his studies at UCLA in the School of Dentistry, graduating with numerous awards. In 2006, Dr. Rohde became one of the founders of Dentalcompare, an online resource that specializes in helping doctors learn about new products and techniques. His practice integrates multiple technologies including the Solea All-Tissue laser, Cone Beam, CAD/CAM, and 3D printing. Dr. Rohde has authored dozens of articles and is an international speaker, covering topics such as digital dentistry, laser dentistry, advanced surgical techniques, and clear aligner therapy.

Dr. Christopher Blair graduated with a B.Sc. in chemistry from York University before completing his Doctor of Dental Surgery Degree at the University of Toronto where he was the recipient of the Dean’s Gold Medal. After graduation, he completed a general practice residency at The Toronto General Hospital. Dr. Blair now maintains a general practice in Oakville, Ontario. He is an avid cyclist and has often combined his passion for cycling with charitable endeavors. Most notably, Dr. Blair is passionate about his efforts to raise funds to support kids living with cancer and who are cancer survivors and to support cancer research. Through his participation in Tour for Kids and The Ride to Conquer Cancer, Dr. Blair has raised thousands of dollars to support Camp Trillium, Camp Quality, and Camp Oochegeas, as well as The Princess Margaret Cancer Centre.

Dr. Jenny Jackson graduated as valedictorian with a degree in microbiology from North Carolina State before attending the Harvard School of Dental Medicine where she was given the Dean’s Community Service Award and was chosen to be a part of the HSDM/Forsyth Institute Research Academy. With a passion for helping children, Dr. Jackson opened her own practice in Asheville, NC in 2007. She currently serves as immediate past president of the North Carolina Academy of Pediatric Dentistry, is an adjunct assistant professor at University of North Carolina Chapel Hill Dental School, and is recognized as a Fellow of the American Academy of Pediatric Dentistry for leadership and service in the field of Pediatric Dentistry.

Dr. Jared Poplin graduated from the University of Kansas with a B.A. in biology. He earned his Doctorate in Dental Medicine from Temple University School of Dentistry and achieved an additional two-year pediatric residency at St. Christopher’s Hospital for Children in Philadelphia while working in a private pediatric dental office. Dr. Poplin has extensive training and experience in nitrous oxide, general anesthesia, and dental trauma. He is also a Diplomate of the American Board of Pediatric Dentistry. Dr. Poplin has volunteered with the Haitian Health Foundation to provide dental care in the rural villages of Haiti. He excels at working with children who are extremely fearful as well as children with special needs.

To learn more about the Solea® All-Tissue Dental Laser, visit www.ConvergentDental.com.

About Convergent Dental

Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers virtually anesthesia-free, blood-free, pain-free experiences that dentists can rely on. Solea is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea® enables increased new patient flow, better clinical outcomes, significant efficiency gains, and the addition of new procedures. Follow the company on Instagram, Facebook, and LinkedIn.

Media Contact

Caitlin D’Entremont, Convergent Dental, 1 508-500-5656, [email protected], https://www.convergentdental.com/ 

Barbara Tabor, Tabor PR, 1 651-230-9192, [email protected]

Twitter, LinkedIn

SOURCE Convergent Dental



Health: Addiction

Innovation Takes Center Stage at the 2023 PDA Pharmaceutical Microbiology Conference

Leave a comment


“Microbiologists and regulators are tasked with answering big and difficult questions, and this can only be achieved by continuing to build our competence, sharing experiences and challenges, and keeping the discipline of pharmaceutical microbiology strong and vibrant,” said conference co-chair Kurt Jaecques, GSK.

“For this year’s conference, PDA and the Program Planning Committee are proud to present a robust program that tackles both current and future issues that will impact pharmaceutical microbiology,” said conference co-chair Vineeta Pradhan, U.S. FDA.

Day one will open with a plenary presentation by three-time cancer survivor Rob Weker, whose story will remind attendees of the enormous purpose of their work in pharmaceutical microbiology. The remainder of the day is packed with concurrent sessions covering multiple, forward-looking topics. Day one concludes with a presentation on pathogen spillover into humans by Assistant Professor of Biology David Kennedy, MD, Pennsylvania State University, who will share insights on a model that will be able to predict the likelihood of microbial transmission. Dr. Kennedy will discuss his research model of using nematodes as a unique host organism and how this model promises to predict future crossovers before they develop into global pandemics.

Day two features more expert discussions of all-important topics like environmental monitoring, risk management and data governance, contamination control strategies, and case studies on the implementation of the new European Union Annex 1: Manufacture of Sterile Medicinal Products.

Day three’s headliner is an eye-opening plenary session featuring Elisabeth Bik, PhD, a scientific integrity consultant and founder of the Science Integrity Digest blog. Dr. Bik will share insights on image duplication, manipulation and other problems in biomedical research. She is known for her work on detecting photomanipulations in scientific publications.

The 18th PDA Pharmaceutical Microbiology Conference concludes with the ever popular “Ask the Regulators” session, where U.S. FDA representatives will field questions posed by the audience.

Click here for more information on the 2023 PDA Pharmaceutical Microbiology Conference.

To request a press pass, click here.

Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation, so members can better serve patients. Go to http://www.pda.org/footer/about-pda to learn more.

Media Contact

Walter Morris, www.pda.org, 1 3016565900, [email protected], www.pda.org

SOURCE www.pda.org